Dr. Sue Yom is an expert in the radiation treatment and management of head, neck and lung cancers.

In her research, Yom studies chemoradiation (a combination of chemotherapy and radiation) for these cancers. She also investigates image-guided radiation therapy and ways to reduce toxic effects using focused radiation techniques, emerging biological agents and radiation protectants.

Yom earned her medical and doctoral degrees at the University of Pennsylvania. She completed a residency in radiation oncology at the MD Anderson Cancer Center.

Yom has received numerous awards recognizing her commitment to patient care and patient-oriented research.

  • Education

    University of Pennsylvania School of Medicine, 2002

  • Residencies

    University of Texas Anderson Cancer Center, Radiation Oncology, 2007

  • Board Certifications

    Radiation Oncology, American Board of Radiology

  • Academic Title

    Professor

I am a passionate advocate for my patients in helping them achieve their best outcomes, both in health and quality of life.

Clinics I work with

Melanoma & Skin Cancer Center

Bakar Precision Cancer Medicine Building

1825 Fourth Street, Third Floor
San Francisco, CA 94158

Radiation Oncology Clinic

See all three of our San Francisco locations.

My reviews

5.0

Overall Experience
192 Reviews
dr Yom inspires confidence in her expertise
Explained things in a way that was easy to understand
192 Reviews
Did the doctor pay attention to your concerns
192 Reviews
Gave easy to understand instructions about taking care of health problems or concerns
184 Reviews
Knew the important information about your medical history
192 Reviews
The provider showed respect for what you had to say
191 Reviews
The provider spent enough time with me
191 Reviews
Decorative Caduceus

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usua...

Estimated using the Kaplan-Meier method for each arm. Their distributions will be compared between treatment arms with a one-sided log rank test.

Recruiting

Decorative Caduceus

Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on ...

Estimated using the Kaplan-Meier method for each arm. Their distributions will be compared between treatment arms with a 1-sided log rank test. The confidence interval approach will be used for the final analysis of OS.

Recruiting

Decorative Caduceus

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in ...

Will be estimated for all treatment arms using the Kaplan-Meier method (1958). The primary phase IIR endpoint will be tested using a confidence interval (CI) approach.

Recruiting

Decorative Caduceus

Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)

The rate of completion of all adjuvant therapy by patients treated at the maximum tolerated dose (MTD) schedule will be determined and compared to a historical control rate of 52%.

Recruiting

Share